| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | BLUEBIRD BIO INC COM | 351,441 | 21,684,000 | 0.21% | ||
| 102 | ARRAY BIOPHARMA INC | 2,585,913 | 22,730,000 | 0.22% | ||
| 103 | XENCOR INC COM | 872,072 | 22,953,000 | 0.23% | ||
| 104 | Merus NV | 1,160,014 | 24,488,000 | 0.24% | ||
| 105 | ACORDA THERAPEUTICS INC | 35,083,000 | 26,570,000 | 0.26% | PRN | |
| 106 | Progenics Pharmaceuticals Inc | 3,150,808 | 27,223,000 | 0.27% | ||
| 107 | FOAMIX PHARMACEUTICALS LTD | 2,466,702 | 27,380,000 | 0.27% | ||
| 108 | VERSARTIS INC | 1,920,845 | 28,621,000 | 0.28% | ||
| 109 | HERON THERAPEUTICS INC COM | 2,383,569 | 31,225,000 | 0.31% | ||
| 110 | NEUROCRINE BIOSCIE COM USD0.001 | 895,422 | 34,653,000 | 0.34% | ||
| 111 | EXELIXIS INC | 3,003,569 | 44,783,000 | 0.44% | ||
| 112 | CERUS CORP | 13,053,275 | 56,782,000 | 0.56% | ||
| 113 | INVITAE CORP | 7,288,300 | 57,869,000 | 0.57% | ||
| 114 | ADVANCED ACCELERATOR APPLIC | 2,167,137 | 57,993,000 | 0.57% | ||
| 115 | ACHAOGEN INC COM | 4,582,382 | 59,663,000 | 0.58% | ||
| 116 | ACORDA THERAPEUTICS INC | 3,301,791 | 62,074,000 | 0.61% | ||
| 117 | SPARK THERAPEUTICS INCORPORATED | 1,318,341 | 65,785,000 | 0.64% | ||
| 118 | BELLICUM PHARMACEUTICALS INCORPORATED | 4,865,647 | 66,270,000 | 0.65% | ||
| 119 | AMARIN CORP PLC | 22,169,509 | 68,282,000 | 0.67% | ||
| 120 | BIOCRYST PHARMACEUTICALS | 10,963,944 | 69,402,000 | 0.68% | ||
| 121 | BIOMARIN PHARMACEUTICAL INC SR SB CV1.875 17 | 22,379,000 | 90,531,000 | 0.89% | PRN | |
| 122 | ABBVIE INC | 1,685,994 | 105,577,000 | 1.03% | ||
| 123 | BEIGENE LTD | 3,673,175 | 111,518,000 | 1.09% | ||
| 124 | AQUINOX PHARMACEUTICALS INC | 10,536,092 | 173,951,000 | 1.71% | ||
| 125 | DBV TECHNOLOGIES S A | 5,509,560 | 193,551,000 | 1.90% | ||
| 126 | BIOMARIN PHARMACEUTICAL INC | 4,806,483 | 398,169,000 | 3.90% | ||
| 127 | GENOMIC HEALTH INC COM | 13,770,302 | 404,709,000 | 3.97% | ||
| 128 | Incyte Corporation | 259,000,000 | 518,139,000 | 5.08% | PRN | |
| 129 | Incyte Corporation | 274,500,000 | 558,650,000 | 5.48% | PRN | |
| 130 | ACADIA PHARMACEUTICALS INC COM | 25,819,768 | 744,642,000 | 7.30% | ||
| 131 | ALEXION PHARMACEUTIC | 6,543,295 | 800,572,000 | 7.85% | ||
| 132 | INCYTE CORP | 23,499,087 | 2,356,253,000 | 23.10% | ||
| 133 | SEATTLE GENETICS INC | 45,711,856 | 2,412,215,000 | 23.65% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008836, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
